BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/23/2022 10:30:01 AM | Browse: 11 | Download: 22
Publication Name World Journal of Clinical Cases
Manuscript ID 80540
Country/Territory China
Category Oncology
Manuscript Type Case Report
Article Title Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report
Manuscript Source Unsolicited Manuscript
All Author List Lu Lu, Li Sha, Yu Feng and Liang Yan
Funding Agency and Grant Number
Funding Agency Grant Number
Shanghai Municipal Health Commission, Shanghai Muricipal Administrator of Traditional Chinese Medicine NO. ZY (2021-2023)-0201-02
Corresponding Author Liang Yan, PhD, Associate Chief Physician, Department of General Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, No. 185 Pu'an Road, Huangpu District, Shanghai 200021, China. yanliang0831@163.com
Key Words Immune checkpoint inhibitor; Colitis; Programmed cell death ligand 1; Infliximab; Laparoscopic surgery; Case report
Core Tip Immune checkpoint inhibitors (ICIs) sometimes lead to diarrhea and colitis, which are routinely treated with immunosuppressive therapy. For ICI-related colitis with ineffective medical treatment, timely surgical intervention could prevent the death of patients.
Citation Lu L, Sha L, Feng Y, Yan L. Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report. World J Clin Cases 2022; In press
2022-10-02 06:26
Peer-Review Started
2022-10-02 06:27
To Make the First Decision
Return for Revision
2022-10-21 01:27
2022-11-02 06:38
Second Decision
2022-11-23 03:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-11-23 10:30
Articles in Press
2022-11-23 10:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-11-20 12:56
Typeset the Manuscript
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Yu-Lu Chen
Reviewer Code 03261497, 06360634, 06271739, and 06303021
Editorial Director
Journal Chief Editor
Company Chief Editor Jin-Lei Wang
Language Editor Tian-Qi Wang
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Manuscript File 80540_Auto_Edited-YLC-Wang TQ-JLW.docx
Answering Reviewers 80540-Answering reviewers.pdf
Audio Core Tip 80540-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 80540-Conflict-of-interest statement.pdf
Copyright License Agreement 80540-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 80540-Grant application form(s).pdf
Signed Consent for Treatment Form(s) or Document(s) 80540-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 80540-Language certificate.pdf
Peer-review Report 80540-Peer-review(s).pdf
Scientific Misconduct Check 80540-Bing-Chen YL-2.png
Scientific Editor Work List 80540-Scientific editor work list.pdf